138 related articles for article (PubMed ID: 8763063)
1. [Depressive disorders and interferon alpha].
Hardy P
Gastroenterol Clin Biol; 1996; 20(3):255-7. PubMed ID: 8763063
[No Abstract] [Full Text] [Related]
2. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
Koff RS
Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
[No Abstract] [Full Text] [Related]
3. [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].
Gournay J; Richou C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B60-75. PubMed ID: 12180310
[No Abstract] [Full Text] [Related]
4. [Therapy of viral hepatitis].
Rambusch EG; Manns MP
Ther Umsch; 1998 Feb; 55(2):71-6, 78-9. PubMed ID: 9545847
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C.
Mundt AP; Sarkar R; Winter C; Schaefer M; Ströhle A
Psychosomatics; 2007; 48(1):86-7. PubMed ID: 17209157
[No Abstract] [Full Text] [Related]
6. Current state of interferon therapy in the treatment of chronic hepatitis B.
Manns MP
Semin Liver Dis; 2002; 22 Suppl 1():7-13. PubMed ID: 12447724
[TBL] [Abstract][Full Text] [Related]
7. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
[No Abstract] [Full Text] [Related]
8. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
Marcellin P
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
[No Abstract] [Full Text] [Related]
9. Case of mania induced by withdrawal of interferon-alpha in a patient affected by bipolar disorder.
Rossi A; Renzetti D; D'Albenzio L; Gianfelice D; Kalyvoka A; Rinaldi O
Psychiatry Clin Neurosci; 2002 Dec; 56(6):647-8. PubMed ID: 12485309
[No Abstract] [Full Text] [Related]
10. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
[TBL] [Abstract][Full Text] [Related]
11. [Chronic hepatitis C in children: are extrahepatic manifestations an argument for standard therapy?].
Azoicăi AN; Moraru E
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1035-41. PubMed ID: 21500456
[TBL] [Abstract][Full Text] [Related]
12. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
[TBL] [Abstract][Full Text] [Related]
13. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
[TBL] [Abstract][Full Text] [Related]
14. Interferon alfa, peginterferon alfa and retinopathy.
Prescrire Int; 2006 Apr; 15(82):61-2. PubMed ID: 16607695
[TBL] [Abstract][Full Text] [Related]
15. [New therapeutic possibilities in chronic hepatitis C].
Criblez DH
Praxis (Bern 1994); 2000 Mar; 89(11):450-3. PubMed ID: 10758732
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C: limits and dose regimen of interferon alfa.
Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha. Amarillo Biosciences.
Barnard DL
Curr Opin Investig Drugs; 2002 May; 3(5):693-7. PubMed ID: 12090541
[TBL] [Abstract][Full Text] [Related]
18. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
Khan HA; Khawaja FI; Mahrous AR
Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
[No Abstract] [Full Text] [Related]
19. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
